menc-hib
Vaccineexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2006 (NCT00381615)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Neisseria meningitidisImmunity, active
Neisseria meningitidis immunity, active
- Haemophilus influenzaeImmunity, active
Haemophilus influenzae immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- menc-hib
- menc/hib vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02482636 | Phase 2 | Aug 1, 2015 | Public Health England, University of London, University of Oxford |
| NCT00381615 | Phase 2 | Sep 1, 2006 | Novartis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novartis | For profit | 1 | 1 | 1 | 2006 |
| Public Health England | Government | 1 | 0 | 1 | 2015 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2015 |
4 organizations
Page 1 / 1